Suntinorexton (TAK 861) is a selective orexin 2 receptor (OX2R) agonist used in neuroscience research. It is employed in both in vitro and in vivo studies to investigate sleep/wake regulation, narcolepsy, and other neurological disorders associated with orexin signaling.